Filing Details
- Accession Number:
- 0001493152-23-025185
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-21 10:06:58
- Reporting Period:
- 2023-07-20
- Accepted Time:
- 2023-07-21 10:06:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 715446 | Anixa Biosciences Inc | ANIX | Pharmaceutical Preparations (2834) | 112622630 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689394 | Michael Catelani | C/O Anixa Biosciences, Inc. 3150 Almaden Expressway, Suite 250 San Jose, CA 95118 | President, Coo & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-07-20 | 5,500 | $3.64 | 26,655 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
